Tagged Articles

lawsuit 3781 articles

J&J buys out Irish medtech company


One of Johnson & Johnson’s subsidiaries has snapped up Irish medtech company Neuravi in a deal that could be worth hundreds of millions of dollars. The consumer health care products and pharmaceutical giant’s DePuy Ireland subsidiary, an affiliate of Johnson & Johnson’s neurosurgery firm, Codman Neuro, purchased the company for an undisclosed sum. Neuravi manufactures a medical device called the EmboTrap that is used to retrieve blood clots in the brain following a stroke in order to restore blood flow to the vein. The device is used in the treatment of acute ischemic strokes, or blockages in the vessels supplying blood ... Read More

Jellyfish protein supplement maker defends memory boosting benefits in court

brain STEPS image

Wisconsin-based Quincy Bioscience told a New York federal court that its advertisements promoting the memory boosting effects of a jellyfish protein are not false or misleading because they are based on the Federal Trade Commission’s (FTC) “gold standard of scientific testing.” The company is facing claims by the FTC and the New York Attorney General’s Office that the company’s cited studies are not valid because they use specific subgroups. Quincy Bioscience argued that it referenced placebo-controlled, double-blind studies to prove the jellyfish protein offered cognitive benefits to users. Quincy Bioscience’s jellyfish protein is sold under the name brand Prevagen and ... Read More

Dietary supplement maker fined for questionable marketing scheme

online shopping - Shutterstock

The owner of two dietary supplements companies settled a lawsuit with the Federal Trade Commission (FTC) over a marketing scheme and false claims regarding its diet pills. The proposed order was filed against Colby Fox and his companies Tachht Inc., and Teqqu LLC, in the U.S. District Court for the Middle District of Florida, Tampa Division. According to the complaint, Fox and his companies paid affiliate marketers to illegally send millions of spam emails to consumers from hacked email accounts. The emails were designed to look like notes from the consumers’ family and friends with links directing consumers to Fox’s websites ... Read More

Talc litigation asks when to warn consumers of health risks

talc justice

An attorney analyzing the legal landscape for the Claims Journal used the talc litigation to examine the issue of failure to warn. He concluded that manufacturers and their insurers can’t assume that the argument that they are waiting on a scientific consensus about an alleged risk associated with their product will protect them from liability. In spite of the fact that scientists are still studying the effects of talc on the female reproductive system and that there is debate over how to interpret the decades of research that has already been done, three juries in 2016 found Johnson and Johnson to be liable ... Read More

J&J blames disappointing 1Q sales on Invokana, Xarelto performance


Johnson & Johnson’s recently reported first quarter earnings report dropped more than 3 percent on the day the news was announced, a rarity for a fairly stable stock, according to NASDAQ analysts. The consumer health care and pharmaceutical giant is blaming the weak first-quarter earnings on price discounting in certain sales channels, as well as competition for the underperformance of its pharmaceuticals. Specifically, sales of J&J’s type 2 diabetes drugs Invokana and Invokamet fell almost 16.8 percent in the U.S. due to lower prices. The company’s blood thinner Xarelto, manufacturered in partnership with Bayer, saw a slight increase in prescription share, ... Read More

Alabama company Pays New York State $40 Million To Settle False Claims Act Tax Fraud Case

IRS tax law whistleblower - Flickr

An Alabama investment group and some of its top executives have agreed to pay New York State $40 million to settle a New York False Claims Act lawsuit brought by a whistleblower who claimed the company committed tax fraud, cheating New York out of millions of dollars in taxes. The settlement is the largest-ever recovery of its kind since New York’s False Claims Act law was expanded to include tax claims. It resolves allegations that Birmingham-based Harbert Management Corporation, sponsor of Harbinger Capital Partners, a $26 billion New York City-based hedge fund, failed to pay millions in state taxes on ... Read More

Lawsuits allege Xarelto is unreasonably dangerous in design


Johnson & Johnson’s Janssen Pharmaceuticals and Bayer face a potential $2.5 billion in potential liability over uncontrolled bleeding allegedly caused by their blockbuster blood thinner Xarelto. More than 16,000 cases are pending in a multidistrict litigation (MDL) in Louisiana, with the bellwether scheduled to start next week. U.S. District Judge Eldon E. Fallon shot down a preemption argument in a defense summary, which allowed state-law design-defect claims by those suing drug companies to move forward. Janssen and Bayer had argued that the defective design claims are preempted by federal law, and that it would be virtually impossible for them to ... Read More

Wrongful Death Lawsuit Filed Against DuPont alleging Carcinogen Exposure


A wrongful death lawsuit has been filed against E.I. DuPont De Nemours, a science and engineering company that makes construction materials, polymers, paints, plastics, printing materials, and more, alleging long-term exposure to “a potent bladder carcinogen known as aminobiphenyl” made a former employee sick. The estate of William Clawson filed the lawsuit in Jefferson County District Court in Texas on April 5, saying Clawson was a long-term employee of DuPont who was exposed to a chemical that led to his death. The suit alleges Clawson’s job description required him to work around aminobiphenyl, a “known human bladder carcinogen,” according to a hazard document produced by ... Read More

Family vows to appeal judge’s decision to ax Risperdal side effects case


The latest lawsuit to go to trial in the Philadelphia Country Court of Common Pleas involving claims that the antipsychotic drug Risperdal caused an adolescent boy to grow disfiguring female breasts was axed mid-trial by the judge overseeing the case because the judge did not support the expert witness’ diagnosis of gynecomastia based solely on photographs. The family of the boy vowed to appeal. The lawsuit is one of more than 5,700 claims in a mass tort program in Philadelphia County alleging Risperdal makers Johnson & Johnson and its subsidiary Janssen Pharmaceuticals withheld data showing that Risperdal use in adolescent boys ... Read More

Retrievable IVC Filter Migrated, Tilted and Eroded

IVC filter

Anthony G. from California has filed a lawsuit against Rex Medical over its Option Retrievable inferior vena cava (IVC) filter, which migrated, tilted and eroded into his vein. Anthony was inserted with a retrievable IVC filter on Sept. 11, 2011 at Carson Tahoe Regional Medical Center in Carson City, Nevada, after a history of blood clots. An IVC filter is a cage-like device inserted the vena cava, the largest vein in the body, and is designed to catch blood clots before they reach the heart or lungs, resulting in pulmonary embolism (PE). Five years after the procedure, when he began experiencing shortness ... Read More